A. Macciocchi

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Richard J. Gralla, M. Lichinitser, S. van der Vegt et al. · Annals of Oncology · 2003 · 471 citations

Medicine, Oncology, Pharmacology +17

Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT₃ receptor antagonist

Peter D. Eisenberg, Jazmin Figueroa‐Vadillo, Rosalio Zamora et al. · Cancer · 2003 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Matti Aapro, Steven M. Grunberg, George Manikhas et al. · Annals of Oncology · 2006 · 340 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy:a dose-ranging clinical study

Peter D. Eisenberg, F. Roy MacKintosh, Paul S. Ritch et al. · Annals of Oncology · 2004 · 153 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model.

Roberto Maffei Facino, M. Carini, Giancarlo Aldini et al. · PubMed · 1993 · 43 citations

Life Sciences, Biochemistry, Pharmacology +17